James H. Goldie

The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

James H. Goldie, Andrew J. Coldman · PubMed · 1984 · 522 citations

Pathology, Drug Resistance Occur, Pharmacotherapy +18

Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.

Martin Gleave, Anthony W. Tolcher, Hideaki Miyake et al. · QUT ePrints (Queensland University of Technology) · 1999 · 174 citations · Full text

Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.

Richard Klasa, Marcel B. Bally, Rita W. Y. Ng et al. · PubMed · 2000 · 107 citations

Immunology, Pathology, Cell Death +21

Energy absorption in Ni-Mn-Ga-polymer composites

J. Feuchtwanger, Sadie Michael, Jiankang Juang et al. · Journal of Applied Physics · 2003 · 74 citations

Materials Science, Energy Absorption, Engineering +14

Neoadjuvant (preoperative) chemotherapy for breast cancer

Joseph Ragaz, Robert Baird, P. Rebbeck et al. · Cancer · 1985 · 46 citations

Surgical Oncology, Metastatic Breast Cancer, Breast Oncology +10